X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8116) 8116
Publication (584) 584
Newsletter (458) 458
Book Review (163) 163
Magazine Article (99) 99
Newspaper Article (49) 49
Book Chapter (11) 11
Dissertation (7) 7
Trade Publication Article (4) 4
Conference Proceeding (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5636) 5636
fluticasone (4785) 4785
fluticasone propionate (3151) 3151
male (3098) 3098
asthma (3014) 3014
female (2999) 2999
index medicus (2870) 2870
administration, inhalation (2376) 2376
asthma - drug therapy (2316) 2316
adult (2193) 2193
respiratory system (2171) 2171
middle aged (1920) 1920
corticosteroids (1798) 1798
androstadienes - administration & dosage (1670) 1670
allergy (1476) 1476
treatment outcome (1388) 1388
budesonide (1339) 1339
child (1292) 1292
aged (1289) 1289
androstadienes - therapeutic use (1254) 1254
adolescent (1220) 1220
salmeterol (1210) 1210
inhaled corticosteroids (1186) 1186
immunology (1164) 1164
double-blind method (1110) 1110
children (1080) 1080
pharmacology & pharmacy (1031) 1031
drug therapy (1021) 1021
pulmonary disease, chronic obstructive - drug therapy (979) 979
obstructive pulmonary-disease (947) 947
bronchodilator agents - administration & dosage (930) 930
double-blind (890) 890
adrenal cortex hormones - administration & dosage (868) 868
drug therapy, combination (808) 808
albuterol - analogs & derivatives (806) 806
steroids (798) 798
bronchodilator agents - therapeutic use (793) 793
anti-inflammatory agents - administration & dosage (771) 771
anti-asthmatic agents - administration & dosage (743) 743
medicine, general & internal (739) 739
care and treatment (736) 736
chronic obstructive pulmonary disease (726) 726
efficacy (724) 724
copd (721) 721
asthma - physiopathology (681) 681
anti-inflammatory agents - therapeutic use (674) 674
anti-asthmatic agents - therapeutic use (672) 672
beclomethasone dipropionate (652) 652
inflammation (645) 645
lung diseases, obstructive (632) 632
salmeterol xinafoate (632) 632
adrenal cortex hormones - therapeutic use (629) 629
drug combinations (623) 623
research (623) 623
androstadienes - adverse effects (619) 619
glucocorticoids (576) 576
dose-response relationship, drug (574) 574
child, preschool (570) 570
therapy (560) 560
dosage and administration (544) 544
exacerbations (543) 543
analysis (530) 530
quality of life (520) 520
albuterol - administration & dosage (514) 514
pediatrics (503) 503
albuterol - therapeutic use (488) 488
safety (477) 477
quality-of-life (475) 475
glucocorticoids - administration & dosage (461) 461
administration, intranasal (456) 456
severity of illness index (454) 454
lung-function (436) 436
budesonide - administration & dosage (432) 432
pulmonary disease, chronic obstructive - physiopathology (425) 425
persistent asthma (415) 415
risk factors (415) 415
abridged index medicus (409) 409
drug administration schedule (408) 408
adults (407) 407
administration, topical (403) 403
allergic rhinitis (402) 402
time factors (394) 394
airway inflammation (391) 391
young adult (391) 391
androstadienes - pharmacology (389) 389
randomized controlled-trial (387) 387
randomized controlled trials as topic (382) 382
glucocorticoids - therapeutic use (378) 378
formoterol (374) 374
clinical trials (372) 372
forced expiratory volume (371) 371
studies (368) 368
nebulizers and vaporizers (367) 367
animals (364) 364
health aspects (362) 362
adrenal cortex hormones - adverse effects (361) 361
diagnosis (361) 361
cross-over studies (360) 360
forced expiratory volume - drug effects (355) 355
respiratory function tests (349) 349
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8163) 8163
German (151) 151
French (121) 121
Japanese (97) 97
Spanish (65) 65
Chinese (27) 27
Italian (21) 21
Polish (15) 15
Russian (13) 13
Portuguese (9) 9
Dutch (8) 8
Swedish (8) 8
Korean (7) 7
Czech (6) 6
Danish (6) 6
Romanian (6) 6
Turkish (4) 4
Slovak (3) 3
Finnish (2) 2
Norwegian (2) 2
Bosnian (1) 1
Croatian (1) 1
Georgian (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 09/2016, Volume 375, Issue 9, pp. 840 - 849
Journal Article
Nature Communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 2229 - 16
Inhaled corticosteroids (ICS) have limited efficacy in reducing chronic obstructive pulmonary disease (COPD) exacerbations and increase pneumonia risk, through... 
INDUCED ASTHMA | IFN-BETA | OBSTRUCTIVE PULMONARY-DISEASE | EXPERIMENTAL RHINOVIRUS INFECTION | BRONCHIAL EPITHELIAL-CELLS | FLUTICASONE PROPIONATE | MULTIDISCIPLINARY SCIENCES | SALMETEROL/FLUTICASONE PROPIONATE | AIRWAY INFLAMMATION | ANTIMICROBIAL PEPTIDES | NF-KAPPA-B | Lung - microbiology | Fluticasone - pharmacology | Pulmonary Disease, Chronic Obstructive - microbiology | Humans | Mucus - virology | Pulmonary Disease, Chronic Obstructive - virology | Mucus - drug effects | Rhinovirus - physiology | Picornaviridae Infections - virology | Bacterial Load - drug effects | Lung - virology | Picornaviridae Infections - prevention & control | Fluticasone - immunology | Receptor, Interferon alpha-beta - genetics | Rhinovirus - immunology | Bacterial Infections - microbiology | Receptor, Interferon alpha-beta - metabolism | Rhinovirus - drug effects | Cell Line | Immunity, Innate - drug effects | Administration, Inhalation | Adrenal Cortex Hormones - pharmacology | Mice, Knockout | Mucus - microbiology | Bacterial Infections - prevention & control | Animals | Fluticasone - administration & dosage | Pulmonary Disease, Chronic Obstructive - prevention & control | Lung - drug effects | Adrenal Cortex Hormones - immunology | Adrenal Cortex Hormones - administration & dosage | Corticoids | Pneumonia | Immune response | Corticosteroids | Secretion | Propionic acid | Lung diseases | Immune clearance | Health risks | Viruses | Mucus | Infections | Fluticasone | Disease control | Antiinfectives and antibacterials | Immunity | TLR3 protein | α-Interferon | Mucin | Obstructive lung disease | Toll-like receptors | Bacteria | Chronic obstructive pulmonary disease | Interferon
Journal Article
Advances in Therapy, ISSN 0741-238X, 1/2018, Volume 35, Issue 1, pp. 56 - 71
Directly recorded patient experience of symptoms and health-related quality of life (HRQoL) can complement lung function and exacerbation rate data in chronic... 
Symptom burden | Rheumatology | Fluticasone furoate/umeclidinium/vilanterol | Internal Medicine | Oncology | Respiratory | COPD burden | Medicine & Public Health | Patient-reported outcomes | Cardiology | Pharmacology/Toxicology | Budesonide/formoterol | Endocrinology | MEDICINE, RESEARCH & EXPERIMENTAL | DYSPNEA | VALIDATION | FLUTICASONE PROPIONATE/SALMETEROL | TRIAL | OBSTRUCTIVE PULMONARY-DISEASE | TIOTROPIUM | PHARMACOLOGY & PHARMACY | OUTCOMES | BURDEN | Bronchodilator Agents - therapeutic use | Bronchodilator Agents - administration & dosage | Humans | Middle Aged | Benzyl Alcohols - administration & dosage | Benzyl Alcohols - adverse effects | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Benzyl Alcohols - therapeutic use | Quinuclidines - administration & dosage | Chlorobenzenes - administration & dosage | Fluticasone - therapeutic use | Forced Expiratory Volume | Quinuclidines - therapeutic use | Adult | Female | Surveys and Questionnaires | Bronchodilator Agents - adverse effects | Drug Therapy, Combination | Fluticasone - adverse effects | Quinuclidines - adverse effects | Double-Blind Method | Drug Administration Schedule | Administration, Inhalation | Budesonide, Formoterol Fumarate Drug Combination - therapeutic use | Chlorobenzenes - adverse effects | Fluticasone - administration & dosage | Chlorobenzenes - therapeutic use | Quality of Life | Dyspnea - drug therapy | Pulmonary Disease, Chronic Obstructive - drug therapy | Medicine, Experimental | Medical research | Respiratory agents | Lung diseases, Obstructive | Care and treatment | Analysis | Budesonide | Original Research | umeclidinium | Fluticasone furoate | vilanterol | formoterol
Journal Article
Pharmaceutical Research, ISSN 0724-8741, 12/2017, Volume 34, Issue 12, pp. 2454 - 2465
To characterise a biorelevant simulated lung fluid (SLF) based on the composition of human respiratory tract lining fluid. SLF was compared to other media... 
Biochemistry, general | dissolution | biopharmaceutics | Biomedical Engineering | inhalation | Biomedicine | Pharmacy | fluticasone propionate | Medical Law | solubility | beclomethasone dipropionate | Pharmacology/Toxicology | aerosol | DRUG | SOLUBILIZATION | CHOLESTEROL | HUMAN INTESTINAL FLUIDS | CHEMISTRY, MULTIDISCIPLINARY | MONOLAYERS | PREDICTION | SURFACTANT | PHARMACOKINETICS | INHALER PRODUCTS | PHARMACOLOGY & PHARMACY | A549 Cells | Beclomethasone - administration & dosage | Fluticasone - chemistry | Beclomethasone - pharmacokinetics | Humans | Solubility | Administration, Inhalation | Asthma - drug therapy | Anti-Asthmatic Agents - pharmacokinetics | Body Fluids - metabolism | Fluticasone - administration & dosage | Fluticasone - pharmacokinetics | Lung - metabolism | Anti-Asthmatic Agents - administration & dosage | Beclomethasone - chemistry | Anti-Asthmatic Agents - chemistry | Beclomethasone dipropionate | Analysis | Fluticasone | Cell culture | Spectroscopy | Media (culture) | Epithelial cells | Propionic acid | Photon correlation spectroscopy | Electron microscopy | Dissolution | Inhalation | Respiratory tract | Transmission electron microscopy | Lungs | Biocompatibility | Alveoli | Respiration | Pharmaceuticals | Research Paper | Fysikalisk kemi | Chemical Sciences | Naturvetenskap | Physical Chemistry | Kemi | Natural Sciences
Journal Article
LANCET, ISSN 0140-6736, 09/2016, Volume 388, Issue 10048, pp. 963 - 973
Background Few data are available for the efficacy of "triple therapy" with two long-acting bronchodilators and an inhaled corticosteroid in chronic... 
POPULATION | MEDICINE, GENERAL & INTERNAL | LUNG-FUNCTION | EXACERBATIONS | INDIVIDUAL COMPONENTS | TIOTROPIUM | FLUTICASONE PROPIONATE/SALMETEROL | GLYCOPYRRONIUM | COPD | SALMETEROL | SALMETEROL/FLUTICASONE
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2016, Volume 374, Issue 23, pp. 2222 - 2234
Journal Article
Journal Article
Respirology, ISSN 1323-7799, 11/2017, Volume 22, Issue S3, pp. 167 - 167
Journal Article
Respirology, ISSN 1323-7799, 11/2017, Volume 22, Issue S3, pp. 176 - 177
Journal Article
Respirology, ISSN 1323-7799, 11/2017, Volume 22, Issue S3, pp. 178 - 178
Journal Article
European respiratory journal, ISSN 0903-1936, 2017, Volume 49, Issue 1, pp. 1600839 - 1600839
Journal Article